COSM Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2024Q4

FY2025Q1

14.50M

-8.46%

15.50M

+6.28%

Estimates Revision

The market is revising No Change the revenue expectations for Cosmos Health Inc. (COSM) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -52.91%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-52.91%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for Cosmos Health Inc (COSM.O) is 51.50, compared to its 5-year average forward P/E of 7.93. For a more detailed relative valuation and DCF analysis to assess Cosmos Health Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

7.93

Current PE

51.50

Overvalued PE

33.68

Undervalued PE

-17.82

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-1.42

Current EV/EBITDA

10.93

Overvalued EV/EBITDA

8.03

Undervalued EV/EBITDA

-10.86

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.21

Current PS

0.26

Overvalued PS

0.46

Undervalued PS

-0.04

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

COSM News & Events

Events Timeline

No data

News

7.5

01-07Globenewswire

MIMARU Launches Clothing-Sharing Service to Lessen Luggage Burden

7.5

2025-12-03Newsfilter

Cosmos Health Partners with Prime Ledger to Manage $300M Treasury and Tokenize IP

5.0

2025-12-02Newsfilter

Cosmos Health CEO Greg Siokas Acquires Over 3.3 Million Shares, Expresses Strong Confidence

People Also Watch

Frequently Asked Questions

What is Cosmos Health Inc (COSM) stock price today?

The current price of COSM is 0.51795 USD — it has decreased -0.19 % in the last trading day.

What is Cosmos Health Inc (COSM)'s business?

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.

What is the price predicton of COSM Stock?

Wall Street analysts forecast COSM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for COSM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cosmos Health Inc (COSM)'s revenue for the last quarter?

Cosmos Health Inc revenue for the last quarter amounts to 17.11M USD, increased 37.86 % YoY.

What is Cosmos Health Inc (COSM)'s earnings per share (EPS) for the last quarter?

Cosmos Health Inc. EPS for the last quarter amounts to -0.17 USD, decreased -62.22 % YoY.

What changes have occurred in the market's expectations for Cosmos Health Inc (COSM)'s fundamentals?

How many employees does Cosmos Health Inc (COSM). have?

Cosmos Health Inc (COSM) has 149 emplpoyees as of January 09 2026.

What is Cosmos Health Inc (COSM) market cap?

Today COSM has the market capitalization of 19.37M USD.